Description: dsom_rgb.bmp

Surgery Grand Rounds

March 11, 2015

Duke North – Room 2002


Surgical D & C Case Conference*

6:00 – 7:00 a.m.

Moderator: Allan D. Kirk, M.D., Ph.D., FACS


*Surgical D & C Conference should be attended by Faculty, Fellows, Residents, and APPs only.


Surgical Grand Rounds


7:00 – 8:00 a.m.


“A New Disease, a New Technique and a New Modality: Therapeutic Targeting of HPV+ Head and Neck Cancer


Robert L. Ferris, M.D., Ph.D., FACS
UPMC Endowed Professor and Chief

Division of Head and Neck Surgery

Vice-Chair for Clinical Operations


Associate Director for Translational Research

Co-Leader, Cancer Immunology Program

University of Pittsburgh Cancer Institute

Pittsburgh, PA


Moderator: Ramon Esclamado, M.D.

Presenter Disclosure of Financial Relationships:  Drs. Kirk and Esclamado indicate that they have no disclosures and no personal/financial relationships to disclose which are relative to this activity.  Dr. Ferris indicates that he is an Advisory Board Member for Astra Zeneca, Bristol-Myers Squibb, Medimmune, VentiRX, and Merck-CureVac, but has no personal/financial relationships to disclose which are relative to this activity.

RSS Activity Medical Director(s) Disclosure: Dr. Ranjan Sudan has no personal/financial relationships to disclose which are relative to this activity.

---Global Learning Objectives---

  1. Review and discuss new advances in general surgery;
  2. Present and discuss case studies, protocols, treatment guidelines and surgical/pathology report appropriate to General Surgery practice;
  3. Review and discuss clinical research findings and other evidence from pertinent literature.


---Accreditation Information---

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


---Unapproved Use Disclosure---

Duke School of Medicine requires CME faculty (speakers) to disclose to the attendees: 1) When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (Not FDA approved) ; and 2) Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and /or unsupported opinion.  Faculty at this event may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling.  This information is intended solely for continuing medical education, and is not intended to promote off-label use of these medications.  If you have any questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.


---Credit Designation---

The Duke University School Of Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in this activity.


In order to receive CME Credit, learners must sign in at the beginning of this event.


Description: Duke_Surgery_cmykweb

Session date: 
Wednesday, March 11, 2015 - 6:00am to 8:00am
DN 2002
United States

Please login or register to take this course.